Journal
CLINICAL TRANSPLANTATION
Volume 28, Issue 1, Pages 58-66Publisher
WILEY
DOI: 10.1111/ctr.12279
Keywords
daytime sleepiness; medication adherence; renal transplantation
Categories
Funding
- Swiss Renal Foundation (Alfred and Erika Bar-Spycher Foundation)
- International Transplant Nurse Society
Ask authors/readers for more resources
BackgroundThe aims of this study were to determine the prevalence of immunosuppressive non-adherence (NA) in renal transplant patients and describe whether the degree of daytime sleepiness (DS) and depressive symptomatology are associated with immunosuppressive NA. MethodsUsing a cross-sectional design, 926 home-dwelling renal transplant recipients who were transplanted at one of three Swiss transplant centers provided data by self-report. The Basel Assessment of Adherence Scale for immunosuppressive was used to measure the following: taking, timing, and overall NA to immunosuppressive medication. DS was assessed with the Epworth Sleepiness Scale (ESS) (cut-off 6 for DS) and the Swiss Transplant Cohort Study DS item (cut-off 4 for DS), and depressive symptomatology was assessed with the Depression, Anxiety, and Stress Scale (cut-off>10). An ordinal logistical regression model was applied for statistical analysis. ResultsThe prevalence of the ESS-DS was 51%. NA for taking, timing, and the median overall NA level assessed by 0-100% visual analog scale (VAS) was 16%, 42%, and 0%, respectively. Based on the multivariate analysis, DS was significantly associated (p<0.001) with taking (1.08 [1.04-1.13]), timing (1.07 [1.03-1.10]), and overall NA (1.09 [1.05-1.13]). Very similar results were found for the Swiss Transplant Cohort Study DS item. ConclusionDS is associated with immunosuppressive medication NA in renal transplant recipients. Admittedly, the association's strength is limited.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available